Winona Reviews: Its Own Pages Disagree on FDA Approval

The one-sentence version

Winona does the thing almost nobody else on this board manages: it publishes a real, single month's price on every one of its eight bioidentical hormone products, from Progesterone Capsules at $39/month up to the Estrogen Patch at "From $149 per month." It also names its own 503A pharmacy classification on a dedicated page. Then two of its own pages contradict each other on the one question a hormone buyer would assume is settled: is the medicine FDA-approved. It grades A, 14 out of 14 — computed from published terms alone, and we hold no affiliate relationship with Winona today.

What it is, and who it's for

Winona is a telehealth company treating perimenopause and menopause, run by physicians including Chief Medical Officer Michael Green, MD. Eligibility starts with a free five-minute quiz — "No blood tests required" — and the site is explicit about why: "In accordance with The Menopause Society and the American College of Obstetrics and Gynecology (ACOG), Winona does not require any type of bloodwork or hormone testing to be prescribed an HRT treatment plan," on the reasoning that hormone levels "fluctuate day to day, and even hour to hour." A board-certified physician reviews the intake and prescribes; typical delivery is about five business days.

The catalogue is bioidentical hormones in patch, cream, capsule and tablet form — estradiol, progesterone, DHEA — plus four non-hormone add-ons (a sleep aid, an arousal cream, a face cream, a hair serum). It does not treat men, and it does not bill insurance; HSA/FSA receipts are the stated workaround. Coverage is 36 states plus Puerto Rico, narrower than an all-50-states competitor. If you want the field it sits in, start with our provider rankings.

What it actually costs

All figures verified on bywinona.com on 4 August 2026.

Every product carries its own monthly figure, printed on the homepage and repeated on each product page — no quiz required to see a number:

• •Progesterone Capsules — $39/month
• •Estrogen Tablets — $54/month
• •Estrogen Body Cream — $89/month
• •Estrogen Body Cream (with Progesterone) — $89/month
• •Progesterone Body Cream — $89/month
• •Vaginal Estrogen Cream — $89/month
• •Deep Sleep — $119/month
• •Estrogen Patch — "From $149 per month"
• •DHEA — $27/3 months

That is a genuinely flat, pre-signup price list — the trap most of this board fails ("starting at," a plan-length floor, a gated quote) is largely absent here. One qualifier survives: the Estrogen Patch page states the word "From" in front of $149, and the product itself ships in five dose strengths — 0.025 mg, 0.0375 mg, 0.05 mg, 0.075 mg and 0.1 mg — with no page stating whether a higher dose costs more than the lowest one.

Billing cadence. Winona's FAQ states plainly: "Payment and prescription for a 30-day supply are automatically processed every 28 days, while those for a 90-day supply are processed every 84 days." That is 13 charges a year on the 30-day cadence, not 12 — a fact the monthly headline doesn't surface.

The refund window is short. "Patients may cancel an order and receive a full refund to their original form of payment only within the 24-hour processing window." After that: "Orders cannot be cancelled, refunded, or returned after the 24-hour cancellation window has passed." You can pause or cancel the subscription going forward at any time — but a processed order itself is final after one day.

Clinical oversight and the pharmacy — and one contradiction

Winona owns and runs its own compounding pharmacies rather than routing through an unnamed network, and says so on a dedicated page: "Winona operates its own pharmacies in order to provide high-quality, effective menopause care. Winona's pharmacies are classified with 503A status because they develop individual prescriptions for each patient." That claim is published on a surface Winona controls, which is what our rubric scores — no individual facility address is given, the same rung CoreAge Rx sits on.

Every prescription includes free, unlimited messaging with an assigned physician for dose questions and adjustments, and the subscription bundles free standard shipping.

Here is the contradiction. Winona's own /pharmacy page states, twice, that its treatments are not FDA-approved: "Although Winona's bioidentical HRT is not regulated by the FDA for approval, Winona strictly uses ingredients from FDA-regulated facilities to produce all prescriptions," and earlier on the same page, "As 503A compounding pharmacies, Winona pharmacies are not directly regulated by the FDA and therefore are not subject to FDA-approval." That is the correct, standard description of a 503A compounding pharmacy — 503A facilities are not FDA-regulated, 503B facilities are.

But the Estrogen Patch product page's own FAQ asks and answers the opposite: "Is the Estrogen Patch FDA approved? Yes, Winona's Estrogen Patch is approved by the FDA." One Winona page tells you nothing it sells has been through FDA approval; another tells you its single most expensive product has. Both cannot be true on their face, and the site does not reconcile them anywhere we could find. If a patch product genuinely is an FDA-approved generic estradiol patch dispensed outside the 503A pharmacy, the site owes a reader that distinction in one sentence — right now it owes two contradictory ones.

The evidence behind what it sells

Winona markets its hormones as "natural, bioidentical" and states plainly that HRT is "considered a safe and effective treatment for most women with no existing risk factors" when "started before the age of 60 or within 10 years of your final menstrual period."

That claim tracks the current clinical consensus, not a marketing invention. The Women's Health Initiative's 2002 randomized controlled trial of combined estrogen-progestin in postmenopausal women is the reason HRT use collapsed for two decades — it found increased risks of breast cancer, coronary heart disease, stroke and venous thromboembolism in its overall study population¹. But that population's average age was 63, more than a decade past a typical menopause onset, and the finding does not transfer cleanly to a woman starting HRT in her late 40s or early 50s for symptom relief. The Menopause Society's 2022 position statement — the field's current standing guidance — states that for symptomatic women under 60 or within 10 years of menopause, "the benefits of hormone therapy are likely to outweigh the risks"². Winona's framing is consistent with that guidance; it is the same "timing hypothesis" the field has settled on since the WHI re-analysis.

Where the site oversells is the word "bioidentical" itself. Winona's marketing implies bioidentical formulations are inherently gentler or safer than FDA-approved synthetic or conjugated hormones — "Since it's functionally indistinguishable from the body's natural hormones, it tends to come with fewer side effects and risks than synthetic HRT." The Menopause Society's position statement does not support a blanket safety edge for compounded bioidentical hormones over FDA-approved bioidentical or synthetic options; it is compounded formulations specifically — not "bioidentical" as a category — that carry the added caveat of unverified dosing consistency, because a 503A pharmacy is not required to meet FDA manufacturing standards. Estradiol and progesterone are available in FDA-approved bioidentical forms already; Winona's advantage over those is convenience and per-product pricing, not a chemistry difference.

Where it's weak, and who should skip it

Skip it if you are outside its 36-state-plus-Puerto-Rico footprint, or if you need insurance billing rather than HSA/FSA reimbursement. Skip it if you might cancel an order within the first day — after that the charge is final. And before you order the Estrogen Patch specifically, ask which of its five doses "$149" refers to, and what the other four cost; the site does not say.

If you proceed, the pricing itself is close to a model for this board: eight real numbers, visible before signup, updated on the product page rather than buried in an intake.

The verdict, against the rubric

Our rubric scores five things out of fourteen: price transparency (4), a genuine longevity line (4), clinical oversight (2), pharmacy disclosure (2) and human support (2). Winona takes all four for price — a real per-product monthly figure, not a "starting at" plan-length trap. It takes four for a genuine longevity line: hormone optimization is the entire catalogue, not a bolt-on. Two for a physician reviewing every intake, two for a stated 503A claim on a page it controls, and two for unlimited included follow-up messaging. Fourteen of fourteen: an A, tied with the several other rows this board has already found at the ceiling.

The one thing worth fixing costs nothing to fix: pick a lane on FDA approval and say the same thing on every page. Until then, a reader who checks both pages — as this review did — finds Winona disagreeing with itself about the one fact a hormone buyer would assume was simplest. Neighbours on this board worth reading next are the Hone Health review and Marek Health review, both hormone-optimization platforms with a different pricing model; the full field is at our provider rankings.